Alveolar-Arterial (Aa) Gradient Explained - Definitions, Equations, Physiology, Implementation, More

Поділитися
Вставка
  • Опубліковано 1 гру 2024

КОМЕНТАРІ • 6

  • @WhiteboardMedicine
    @WhiteboardMedicine  2 роки тому

    Thanks for checking out the video!
    @WhiteBoardDoct1
    www.patreon.com/WBDR
    www.buymeacoffee.com/WBDR
    www.paypal.com/donate?hosted_button_id=UQN2JGSYSQJEG
    UA-cam Members  Join On HomePage!

  • @davidmbeckmann
    @davidmbeckmann 2 роки тому +4

    I would tell the CoVid people that there would be a morning ABG daily. I then ran their ( A-a ) gradient. In patients dying of CoVid, their gradient increases daily. I saw them into the 500's. I assessed their work of breathing daily and when this increases, it's always from decreasing compliance in the lungs. These patients actually looked like shunt patents with their refractory hypoxemia. Will you move now to " intrapulmonary shunt calculation "? Well done as always!

    • @WhiteboardMedicine
      @WhiteboardMedicine  2 роки тому +3

      That’s actually quite interesting! Thanks for sharing. We may have to try this out. Hah! We will add it to the list!

  • @debigdogk9563
    @debigdogk9563 7 місяців тому +1

    Awesome great teaching, thank you ❤❤❤❤❤

  • @paulelkins425
    @paulelkins425 2 роки тому

    Very interesting video! I'd love to hear you relate the use of the Aa gradient to severe Covid-19.
    From my limited perspective here are my thoughts:
    I suspect Covid-19 patients would have progressively raised Aa as their disease severity progresses. I suspect there would be diffusion due to hyaluronic acid accumulation in the alveoli. I also think there would be a VQ mismatch due to microthrombosis blocking the capillaries. Initially I think it would likely be caused by platelet agglutination and then progressing to vascular injury where VWF would trigger the clotting cascade. This would be confirmed with a delayed elevated D-Dimer.
    As the disease progresses I suspect there are compensatory R to L pulmonary shunts developed around the capillaries, but they won't oxygenate efficiently. I think an elevated VEGF would indicate these new pathways are being created through angiogenesis.
    I'm curious if closely monitoring the Aa gradient during the disease progression could be used to confirm the presence of these events and elucidate the pathogenesis. I'm still not clear on if the microthrombosis is driving the severe disease or if it's the pulmonary inflammation initially.